These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 658630)

  • 21. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE; Mazzaferri EL; Cataland S
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man.
    Füessl HS; Yiangou Y; Ghatei MA; Goebel FD; Bloom SR
    Eur J Clin Invest; 1990 Oct; 20(5):525-9. PubMed ID: 2124984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal gastric inhibitory polypeptide response to oral glucose in hypothyroidism.
    Hays JH; Silverman E; Potter BB; Shakir KM
    J Endocrinol; 1994 Feb; 140(2):309-12. PubMed ID: 8169563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
    Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
    Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
    Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
    Metabolism; 2003 Dec; 52(12):1579-85. PubMed ID: 14669159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of gastric inhibitory polypeptide (GIP) during calcium infusion and in hyperparathyroidism.
    Toyota T; Nakanome C; Akai H; Umezu M; Goto Y
    Regul Pept; 1982 Jun; 4(1):1-12. PubMed ID: 6750703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
    Elahi D; Andersen DK; Tobin JD; Andres R
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels.
    Creutzfeldt W; Ebert R; Willms B; Frerichs H; Brown JC
    Diabetologia; 1978 Jan; 14(1):15-24. PubMed ID: 627329
    [No Abstract]   [Full Text] [Related]  

  • 29. Determinants of gastric inhibitory polypeptide and insulin secretion.
    Williams RH; May JM; Biesbroeck JB
    Metabolism; 1981 Jan; 30(1):36-40. PubMed ID: 7007799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
    Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
    J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
    Levitt NS; Vinik AI; Child PT
    J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y; Furukawa Y; Sato T; Yumita S; Bloom SR
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):98-109. PubMed ID: 7044844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).
    Stöckmann F; Ebert R; Creutzfeldt W
    Diabetes; 1984 Jun; 33(6):580-5. PubMed ID: 6373462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation of food restriction.
    Willms B; Ebert R; Creutzfeldt W
    Diabetologia; 1978 Jun; 14(6):379-87. PubMed ID: 669102
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastric inhibitory polypeptide (GIP) (author's transl].
    Ebert R; Finke U
    Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.
    Sarson DL; Kopelman PG; Besterman HS; Pilkington TR; Bloom SR
    Diabetologia; 1983 Nov; 25(5):386-91. PubMed ID: 6360777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of total parenteral nutrition (TPN) on the enteroinsular axis in the rat.
    Pederson RA; Innis SM; Buchan AM; Chan CB; Brown JC
    Regul Pept; 1985 Mar; 10(2-3):199-206. PubMed ID: 3922014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
    Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.